Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5567817 | PF PRISM CV | Triazole antifungal agents |
May, 2016
(7 years ago) | |
US6632803 | PF PRISM CV | Pharmaceutical formulations containing voriconazole |
Jun, 2018
(5 years ago) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Patient Population(NPP) | Jan 29, 2022 |
Market Authorisation Date: 24 May, 2002
Treatment: Treatment of fungal infections
Dosage: TABLET;ORAL; INJECTABLE;INTRAVENOUS; FOR SUSPENSION;ORAL